Breast cancer is a heterogeneous group of diseases that exhibit various clinical characteristics, course of disease, and response to treatment; it is broadly categorized into luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-enriched, and basal-like (or triple-negative) subtypes [1, 2]. Here, ERBB2 is linked to breast carcinoma.